Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Bladder Cancer
Interventions
DIAGNOSTIC_TEST

Onco4D Biodynamic Chemotherapy Selection Assay

The Onco4D Biodynamic Chemotherapy Selection Assay uses Motility Contrast Tomography (MCT) to measure ex-vivo fresh tumor biopsy response when challenged by an array of chemotherapeutic agents. A machine learning algorithm uses the MCT datastream to predict in vivo tumor response or non response to chemotherapy.

Trial Locations (1)

46241

RECRUITING

Animated Dynamics, Inc., Indianapolis

Sponsors
All Listed Sponsors
lead

Animated Dynamics, Inc.

INDUSTRY

NCT03739177 - Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients | Biotech Hunter | Biotech Hunter